ARDELYX INC
For the period ended Mar 31, 2024. Filed May 2, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 2, 2024
ARDX$2.93+1.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Balance Sheets (unaudited)
CONDENSED BALANCE SHEETS
(in thousands, except share and per share amounts)
| March 31,2024 | December 31,2023 | |
|---|---|---|
| (Unaudited) | ||
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $36,147 | $21,470 |
| Short-term investments | 166,431 | 162,829 |
| Accounts receivable | 28,162 | 22,031 |
| Inventory | 9,813 | 12,448 |
| Prepaid commercial manufacturing | 5,519 | 18,925 |
| Prepaid expenses and other current assets | 11,867 | 8,408 |
| Total current assets | 257,939 | 246,111 |
| Inventory, non-current | 69,045 | 37,039 |
| Prepaid commercial manufacturing, non-current | 4,235 | 4,235 |
| Right-of-use assets | 4,641 | 5,589 |
| Property and equipment, net | 1,019 | 1,009 |
| Other assets | 5,503 | 3,596 |
| Total assets | $342,382 | $297,579 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $17,277 | $11,138 |
| Accrued compensation and benefits | 6,727 | 12,597 |
| Current portion of operating lease liability | 4,314 | 4,435 |
| Deferred revenue | 6,586 | 7,182 |
| Accrued expenses and other current liabilities | 21,991 | 15,041 |
| Total current liabilities | 56,895 | 50,393 |
| Operating lease liability, net of current portion | 778 | 1,725 |
| Long-term debt, net of current portion | 99,834 | 49,822 |
| Deferred revenue, non-current | 12,103 | 8,644 |
| Deferred royalty obligation related to the sale of future royalties | 21,881 | 20,179 |
| Total liabilities | 191,491 | 130,763 |
| Commitments and contingencies (Note 14) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value; 5,000,000 shares authorized; no shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively. | — | — |
| Common stock, $0.0001 par value; 500,000,000 shares authorized; 233,959,744 and 232,453,190 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively. | 23 | 23 |
| Additional paid-in capital | 1,023,610 | 1,012,773 |
| Accumulated deficit | (872,722) | (846,204) |
| Accumulated other comprehensive (loss) income | (20) | 224 |
| Total stockholders’ equity | 150,891 | 166,816 |
| Total liabilities and stockholders’ equity | $342,382 | $297,579 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.